Current studies into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating promising effects in treating weight gain and related second-type diabetes. Animal evidence suggest a unique mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/